Monogram Orthopaedics Inc. Common Stock Cash Flow Conversion Efficiency
Monogram Orthopaedics Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) has a cash flow conversion efficiency ratio of -0.267x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.30 Million) by net assets ($8.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Monogram Orthopaedics Inc. Common Stock (2017–2024)
Cash flow conversion efficiency of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024. This chart illustrates how Monogram Orthopaedics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Monogram Orthopaedics Inc. Common Stock stock quote for real-time trading data and today's change.
Monogram Orthopaedics Inc. Common Stock Cash Flow Conversion Ratio Explained
Monogram Orthopaedics Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Monogram Orthopaedics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monogram Orthopaedics Inc. Common Stock ranked by their cash flow conversion efficiency. Also see Monogram Orthopaedics Inc. Common Stock (MGRM) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Poya International Co Ltd
TWO:5904
|
0.197x |
|
Secuoya Grupo de Comunicación S.A
MC:SEC
|
0.018x |
|
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA
|
-0.130x |
|
Aviat Networks Inc
NASDAQ:AVNW
|
0.012x |
|
Jiin Yeeh Ding Enterprise Co Ltd
TWO:8390
|
0.026x |
|
KinderCare Learning Companies, Inc.
NYSE:KLC
|
0.108x |
|
Apollo Pipes Limited
NSE:APOLLOPIPE
|
0.032x |
|
Highview Merger Corp. Class A Ordinary Share
NASDAQ:HVMC
|
0.016x |
Annual Cash Flow Conversion Efficiency for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual cash flow conversion efficiency of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024. Review Monogram Orthopaedics Inc. Common Stock (MGRM) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $14.50 Million | $-13.97 Million | -0.963x | +4.72% |
| 2023-12-31 | $13.40 Million | $-13.54 Million | -1.011x | +50.18% |
| 2022-12-31 | $4.15 Million | $-8.42 Million | -2.029x | +22.46% |
| 2021-12-31 | $3.50 Million | $-9.17 Million | -2.617x | -141.63% |
| 2020-12-31 | $4.99 Million | $-5.40 Million | -1.083x | -128.37% |
| 2019-12-31 | $-274.63K | $-1.05 Million | 3.817x | +1630.44% |
| 2018-12-31 | $-1.39 Million | $-306.87K | 0.221x | -75.86% |
| 2017-12-31 | $-677.81K | $-619.37K | 0.914x | -- |
About Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more